Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Expanded Access Protocol (EAP) For Subjects Receiving Lisocabtagene Maraleucel That Is Nonconforming For Commercial Release

Disease Sites:

Lymphoma

Staging:

N/A

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Oluwole, Olalekan

Scope:

International

Participating Institutions:

Vanderbilt University

Open Date:

04-07-2026

Trial Type:

Treatment

Protocol ID:

VICCCTT24506

National Clinical Trial ID:

NCT04400591

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available